Publicaciones en colaboración con investigadoras/es de Universidad de Cantabria (29)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry

    PloS one, Vol. 18, Núm. 9, pp. e0290998

  3. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy

    Clinical and experimental rheumatology, Vol. 40, Núm. 5, pp. 988-992

2021

  1. Decisiones de no ingreso en las Unidades de Cuidados Intensivos como medida de limitación de los tratamientos de soporte vital: variabilidad geográfica en España

    Cuadernos de bioética, Vol. 32, Núm. 104, pp. 37-48

  2. HLA association with the susceptibility to anti-synthetase syndrome

    Joint Bone Spine, Vol. 88, Núm. 3

  3. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1201-1205

  2. Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes

    Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240

  3. Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 10, pp. 3056-3061

  4. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 37, Núm. 3, pp. 465-473

2018

  1. Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients

    Human Immunology, Vol. 79, Núm. 6, pp. 499-505

2017

  1. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA

    Rheumatology International, Vol. 37, Núm. 4, pp. 479-485

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  2. Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates

    American Journal of Transplantation, Vol. 15, Núm. 3, pp. 715-722

2012

  1. Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: Results of an open-label, phase 3b study

    Journal of Pain Research, Vol. 5, pp. 121-138

  2. Toll-like receptor 9 gene polymorphisms in polymyalgia rheumatica and giant cell arteritis

    Scandinavian Journal of Rheumatology